NO169172C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte dipeptider - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte dipeptider

Info

Publication number
NO169172C
NO169172C NO834294A NO834294A NO169172C NO 169172 C NO169172 C NO 169172C NO 834294 A NO834294 A NO 834294A NO 834294 A NO834294 A NO 834294A NO 169172 C NO169172 C NO 169172C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
active substituted
analogy procedure
substituted dipeptides
Prior art date
Application number
NO834294A
Other languages
English (en)
Norwegian (no)
Other versions
NO834294L (no
NO169172B (no
Inventor
Joel Gilbert Berger
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO834294L publication Critical patent/NO834294L/no
Publication of NO169172B publication Critical patent/NO169172B/no
Publication of NO169172C publication Critical patent/NO169172C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/373Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in doubly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO834294A 1982-11-26 1983-11-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte dipeptider NO169172C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44476182A 1982-11-26 1982-11-26
US48346383A 1983-04-11 1983-04-11

Publications (3)

Publication Number Publication Date
NO834294L NO834294L (no) 1984-05-28
NO169172B NO169172B (no) 1992-02-10
NO169172C true NO169172C (no) 1992-05-27

Family

ID=27034046

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834294A NO169172C (no) 1982-11-26 1983-11-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte dipeptider

Country Status (11)

Country Link
KR (1) KR910002549B1 (fr)
AU (1) AU565481B2 (fr)
CA (1) CA1250091A (fr)
DK (1) DK533483A (fr)
FI (1) FI78917C (fr)
HU (1) HU193887B (fr)
IL (1) IL70309A (fr)
NO (1) NO169172C (fr)
NZ (1) NZ206362A (fr)
OA (1) OA07594A (fr)
PT (1) PT77699B (fr)

Also Published As

Publication number Publication date
DK533483D0 (da) 1983-11-22
FI78917C (fi) 1989-10-10
HU193887B (en) 1987-12-28
KR910002549B1 (ko) 1991-04-24
PT77699B (en) 1986-05-12
FI834280A (fi) 1984-05-27
PT77699A (en) 1983-12-01
FI834280A0 (fi) 1983-11-23
NZ206362A (en) 1988-11-29
KR840007568A (ko) 1984-12-08
NO834294L (no) 1984-05-28
IL70309A0 (en) 1984-02-29
DK533483A (da) 1984-05-27
AU2157783A (en) 1984-05-31
FI78917B (fi) 1989-06-30
OA07594A (fr) 1985-03-31
IL70309A (en) 1988-11-30
AU565481B2 (en) 1987-09-17
NO169172B (no) 1992-02-10
CA1250091A (fr) 1989-02-14

Similar Documents

Publication Publication Date Title
NO160368C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske azoforbindelser.
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO155133C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme dicykliske forbindelser.
NO162024C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO158060C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO834729L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO167923C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidsubstituerte heterocykliske forbindelser
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO833521L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme vinylthioacetamido-oxacefalosporinderivater
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.